A study to see if a new blood test can diagnose prostate cancer
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Cancer type:
Status:
Phase:
This study is looking at a new blood test called BiopSave that may be able to help diagnose prostate cancer.
More about this trial
If you have symptoms that could be caused by prostate cancer, you are likely to have a prostate biopsy. But often, a biopsy doesn’t find any cancer cells and may not always be necessary. Researchers are looking for ways to work out which men should have a biopsy and which men are unlikely to have prostate cancer, so could avoid having a biopsy.
In this study, they are looking at a blood test called BiopSave. Every man taking part has the blood test and a prostate biopsy. The researchers will compare the results of the blood test with the results of the biopsy.
Some men will go on to be diagnosed with prostate cancer, others will not. If you are diagnosed with prostate cancer, taking part in this study will not affect your treatment in any way.
The aim of the study is to see if the BiopSave test can predict what the result of a prostate biopsy will be. If the test can do this, it may lead to fewer men needing to have a biopsy in the future.
Who can enter
You may be able to enter this trial if you are having tests at the Freeman Hospital in Newcastle and you
- Are going to have a prostate biopsy because you have symptoms that could be caused by prostate cancer
- Are between 40 and 80 years of age
You cannot enter this trial if you
- Have had any other cancer in the last 5 years
- Are hepatitis B, hepatitis C or HIV positive, or have any other disease that can be passed on through blood
Trial design
If you agree to take part in this trial, the study team will take a blood sample and ask you some questions about any other medicines you take.
They will check your medical notes later to see what the result of the biopsy was and compare this with the blood test result.
Hospital visits
Taking part in this study does not involve any extra hospital visits.
Side effects
You may have a small bruise where you have the blood test. But the study team will try to take the blood sample at the same time as you have another blood test.
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Dr David Bramwell
Supported by
Biosignatures Ltd
NIHR Clinical Research Network: Cancer
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040